- $1.91tn
- $1.89tn
- $60.92bn
2020 January 26th | 2021 January 31st | 2022 January 30th | 2023 January 29th | 2024 January 28th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,918 | 16,675 | 26,914 | 26,974 | 60,922 |
Cost of Revenue | |||||
Gross Profit | 6,768 | 10,518 | 18,121 | 16,053 | 44,924 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,072 | 12,143 | 16,873 | 22,750 | 27,950 |
Operating Profit | 2,846 | 4,532 | 10,041 | 4,224 | 32,972 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,970 | 4,409 | 9,941 | 4,181 | 33,818 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,796 | 4,332 | 9,752 | 4,368 | 29,760 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,796 | 4,332 | 9,752 | 4,368 | 29,760 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,796 | 4,332 | 9,752 | 4,368 | 29,760 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.15 | 1.78 | 4.1 | 2.29 | 12.2 |
Dividends per Share |